Medigen Vaccine Biologics : Board of directors has resolved to issue 1st of unsecured convertible corporate bonds

Close

Today's Information

Provided by: Medigen Vaccine Biologics Corporation
SEQ_NO	2	Date of announcement	2022/03/01	Time of announcement	16:14:04
Subject	Board of directors has resolved to issue 1st of unsecured convertible corporate bonds
Date of events	2022/03/01	To which item it meets	paragraph 11
Statement	1.Date of the board of directors resolution:2022/03/01 2.Name [issue no.__ of (secured, unsecured) corporate bonds of ___________ (company)]: issue 1st of unsecured convertible corporate bonds of Medigen vaccine biologics corporation. 3.Whether to adopt shelf registration(Yes/No):No. 4.Total amount issued: equals to the ceiling NT$1,750,000,000 5.Face value per bond:NT$100,000 6.Issue price::Issued at 100% ~ 100.5% of the face value 7.Issuance period:3 years 8.Coupon rate:The coupon rate is 0% per annum 9.Types, names, monetary values and stipulations of collaterals:none. 10.Use of the funds raised by the offering and utilization plan: Enrichment of working capital 11.Underwriting method:Public underwriting will be carried out by way of enquiry and book building 12.Trustees of the corporate bonds:Authorize the chairman's decision. 13.Underwriter or agent:Authorize the chairman's decision. 14.Guarantor(s) for the issuance:Authorize the chairman's decision. 15.Agent for payment of the principal and interest: Authorize the chairman's decision. 16.Certifying institution:N/A 17.Where convertible into shares, the price and the rules for conversion: Relevant measures will be handled in accordance with relevant laws and regulations and reported to government authority. a further announcement will be made after approval. 18.Sell-back conditions: Relevant measures will be handled in accordance with relevant laws and regulations, and will be announced separately after being reported to government authority for approval. 19.Buyback conditions: Relevant measures will be handled in accordance with relevant laws and regulations, and will be announced separately after being reported to government authority for approval. 20.Reference date for any additional share exchange, stock swap, or subscription: Relevant measures will be handled in accordance with relevant laws and regulations, and will be announced separately after being reported to government authority for approval. 21.Possible dilution of equity in case of any additional share exchange, stock swap, or subscription: Relevant measures will be handled in accordance with relevant laws and regulations, and will be announced separately after being reported to government authority for approval. 22.Any other matters that need to be specified: The issue amount,conditions and issue of first domestic unsecured convertible corporate bonds, and revision of conversion method, and total amount of funds required for this plan, the source of funds, the planned projects, the progress of funds,expected benefits and other issues related to issuance. When it's necessary to make or amend due to objective circumstances, the Company authorizes the chairman of the board to deal with it.